Disclosure Panels Details Page
Myeloproliferative Neoplasms Panel - Disclosures as of 04/19/2024
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Date Completed |
|---|---|---|---|---|---|
| Peter Abdelmessieh DO,MSc | None | Bristol Myers Squibb CTI BioPharma Corp. |
None | None | 09/15/2023 |
| Haris Ali MD | CTI BioPharma Corp. Incyte Corporation Karyopharm Therapeutics Stemline |
AbbVie, Inc. GSK Incyte Corporation Karyopharm Therapeutics |
None | None | 02/19/2024 |
| Mary Anne Bergman | None | None | None | None | 02/01/2024 |
| Marian Birkeland PhD | None | None | None | None | 04/02/2024 |
| Nicole Blankenhorn | None | None | None | None | 03/04/2024 |
| Mariana Castells PhD,MD | Blueprint Medicines Cogent Biosciences Current Allergy and Asthma Reports- Editor in Cheif NIHDSMB Allergy Clinical Trials |
AAAAI Foundation Board of Directors ABAI Board of Directors Daiichi Sankyo Inc The Mastocytosis Society Medical Advisory Board |
None | None | 01/08/2024 |
| Ruth Fein Revell BS | None | GSK | None | None | 01/11/2024 |
| Aaron Gerds MD,MS | Bristol Myers Squibb Disc Medicines Eli Lilly and Company GSK Ionis Janssen Pharmaceutica Products, LP Kartos MorphoSys AG Protagonist |
AbbVie, Inc. GSK Rain Oncology |
None | None | 02/14/2024 |
| Jason Gotlib MS,MD | AbbVie, Inc. Blueprint Medicines Bristol Myers Squibb Cogent Biosciences Incyte Corporation Kartos Protagonist Therapeutics |
Blueprint Medicines Cogent Biosciences Incyte Corporation |
None | None | 08/17/2023 |
| Steven Green MD | AbbVie, Inc. Boston Biomedical |
None | GSK | None | 10/15/2023 |
| Kristina Gregory MSN,RN | None | None | None | None | 01/10/2024 |
| Krishna Gundabolu MBBS,MS,FACP | None | Autolus ImCheck Therapeutics Novartis Pharmaceuticals Corporation |
None | Stock in Geron | 01/19/2024 |
| Evelyn Handel PharmD,BCPS,BCOP | None | None | None | None | 02/02/2024 |
| Laura Hanisch PsyD | None | None | None | None | 12/12/2023 |
| Erin Hesler | None | None | None | None | 12/22/2023 |
| Elizabeth Hexner MS,MD | American Board of Internal Medicine Blueprint Medicines Tmunity |
AbbVie, Inc. PharmaEssentia |
None | None | 02/22/2024 |
| Cindy Hochstetler PhD | None | None | None | None | 02/16/2024 |
| Tania Jain MBBS | None | None | AbbVie, Inc. Blueprint Medicines Bristol Myers Squibb cogent biosciences inc CTI BioPharma Corp. Incyte Corporation Kite Pharma Protagonist therapeutics Takeda Pharmaceuticals North America, Inc. Telio pharma |
None | 08/11/2023 |
| Catriona Jamieson PhD,MD | None | None | None | Aspera Biomedicines|Forty Seven, Inc. | 06/13/2022 |
| Paul Kaesberg MD | None | None | BeiGene Incyte Corporation Janssen Pharmaceutica Products, LP |
None | 03/23/2023 |
| Andrew Kuykendall MD | Blueprint Medicines Bristol Myers Squibb Geron GSK Incyte Corporation Janssen Pharmaceutica Products, LP MorphoSys AG Novartis Pharmaceuticals Corporation Protagonist |
AbbVie, Inc. Blueprint Medicines Bristol Myers Squibb GSK Incyte Corporation Karyopharm Therapeutics MorphoSys AG PharmaEssentia Protagonist |
None | None | 04/01/2024 |
| Yazan Madanat MD | None | Blueprint Medicines Bristol Myers Squibb GERON Kura Oncology, Inc. MorphoSys AG Novartis Pharmaceuticals Corporation Rigel pharmaceuticals Sierra Oncology Stemline Therapeutics Taiho Pharmaceuticals Co., Ltd. |
None | None | 01/10/2024 |
| Naveen Manchanda MD | None | None | None | None | 01/23/2024 |
| Lucia Masarova MD | Bristol Myers Squibb Cellenkos Galecto Incyte Corporation NS Pharma PharmaEssentia Pharmaxis |
MorphoSys AG | None | None | 12/29/2023 |
| Jori May MD | None | Legal expert witness | None | None | 03/16/2024 |
| Brandon McMahon MD | None | CTI BioPharma Corp. GSK PharmaEssentia |
None | None | 02/14/2024 |
| Sanjay Mohan MD,MSCI | Ichnos Incyte Corporation Kartos Karyopharm Therapeutics Taiho Pharmaceuticals Co., Ltd. |
None | None | None | 01/29/2024 |
| Kalyan Nadiminti MD | None | AbbVie, Inc. CTI BioPharma Corp. |
None | None | 11/06/2023 |
| Stephen Oh PhD,MD | None | AbbVie, Inc. Bristol Myers Squibb Cogent Constellation CTI BioPharma Corp. Geron Incyte Corporation Protagonist Sierra Oncology |
None | None | 02/25/2023 |
| Jeanne Palmer MD | CTI BioPharma Corp. Incyte Corporation Ionis Morphosys Pharmessentia Protagonist Sierra Oncology |
MorphoSys AG | None | None | 06/26/2023 |
| Ami Patel MD | Genentech, Inc. | None | Binaytara Foundation OncLive |
None | 02/16/2024 |
| Anand Patel MD | Kronos Bio Pfizer Inc. Sumitomo |
Sobi | None | None | 04/15/2024 |
| Nikolai Podoltsev PhD,MD | AI Therapeutics Aptose Biosciences Arog Pharmaceuticals Astellas Pharma US, Inc. Astex Pharmaceuticals Boehringer Ingelheim GmbH Celgene Corporation CTI BioPharma Corp. Daiichi- Sankyo Co. Genentech, Inc. Jazz Pharmaceuticals Inc. MorphoSys AG Pfizer Inc. PharmaEssenita Protagonist Therapeutics Sunesis Pharmaceuticals, Inc. |
AbbVie, Inc. Aptos Biosciences Cogent Biosciences MorphoSys Sobi |
None | None | 03/04/2024 |
| Donna Powell CMD,DHSc,RT(T) | None | None | None | None | 03/13/2024 |
| Lindsay Rein MD | Blueprint Medicines Cogent Geron Corporation Imago Incyte Corporation Karyopharm Therapeutics Kiadis Corporation Merck & Co., Inc. Novartis Pharmaceuticals Corporation PharmaEssentia Protagonist Sumitomo |
AbbVie, Inc. CTI BioPharma Corp. Incyte Corporation MorphoSys AG Novartis Pharmaceuticals Corporation Sumitomo |
None | None | 02/06/2024 |
| Rachel Salit MD | Incyte Corporation | None | None | None | 04/15/2024 |
| Mary Sehl MD | NA | NA | NA | NA | Pending |
| Moshe Talpaz MD | None | Bristol Myers Squibb Novartis Pharmaceuticals Corporation Sumitomo |
None | None | 01/02/2024 |
| Amanda Visnick OCN,RN,BSN | None | None | None | None | 04/12/2024 |
| Martha Wadleigh MD | None | None | None | None | 04/09/2024 |
| Sarah Wall MD,MPH | AbbVie, Inc. CTI BioPharma Corp. Telios Pharma |
Bristol Myers Squibb | None | None | 05/17/2023 |